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ed March 12, 2013.he objective of this study was to examine trends in predicted 10-year risk for coronary heart disease (CHD) and
cardiovascular disease (CVD) from 1999 to 2000 and from 2009 to 2010 among adults in the United States.Background Examining trends in predicted risk for CHD and CVD may offer insights into the direction of cardiovascular health.Methods Data from 7,751 fasting participants, ages 30 to 74 years, of 6 consecutive 2-year cycles of the National Health and
Nutrition Examination Survey were used. Predicted 10-year risk for CHD and CVD was calculated using risk
equations derived from data from the Framingham Heart Study.Results Mean predicted 10-year risk for CHD was 7.2% during 1999 to 2000 and 6.5% during 2009 to 2010 (p for linear
trend ¼ 0.005), and for CVD it was 9.2% during 1999 to 2000 and 8.7% during 2009 to 2010 (p for linear trend ¼
0.152). Mean predicted risk for CHD and CVD declined signiﬁcantly among participants ages 40 to 49 years, 50 to
59 years, 60 to 74 years, and among women. Mean predicted risk for CHD declined signiﬁcantly among men and
whites but nonsigniﬁcantly among Mexican Americans (p for linear trend ¼ 0.067). Mean predicted risk increased
nonsigniﬁcantly among African Americans for both CHD (p for linear trend ¼ 0.063) and CVD (p for linear trend ¼
0.059). Of the modiﬁable cardiovascular risk factors included in the risk equations, favorable trends were noted for
mean systolic and diastolic blood pressure, mean concentrations of total cholesterol and high-density lipoprotein
cholesterol, and smoking status. The prevalence of diabetes mellitus worsened.Conclusions Predicted 10-year risk for CHD improved modestly. Reversing the seemingly rising trend in risk among African-
American adults should be a high priority. (J Am Coll Cardiol 2013;61:2249–52) ª 2013 by the American College
of Cardiology FoundationNational data about incident coronary heart disease (CHD)
and cardiovascular disease (CVD) in the United States have
proven historically difﬁcult to collect, and consequently,
alternative sources of information are needed to generate
insights into this essential surveillance need. In recent years,
several regional U.S. studies have shown decreases in
incident CHD (1). Examining the trend in predicted risk for
CHD and CVD represents a potential window into the
future dynamics of incident CHD and CVD. Previous
studies have examined changes in predicted 10-year risk of
CHD using national data through 2004 (2,3). The objective
of the current study is to examine recent trends in predicted
risk for CHD and CVD among U.S. adults.ealth, National Center for Chronic Disease
Centers for Disease Control and Prevention,
nclusions in this article are those of the author
ﬁcial position of the Centers for Disease Control
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, 2012; revised manuscript received January 30,Methods
Data from 6 consecutive 2-year cycles of NHANES
(National Health and Nutrition Examination Survey) from
1999 to 2000 and 2009 to 2010 were used (4). Using
a multistage, stratiﬁed sampling design, NHANES selected
national samples representative of the civilian, noninstitu-
tionalized U.S. population. Trained interviewers adminis-
tered study questionnaires to participants in their homes and
extended an invitation to participants to have an examina-
tion at a mobile examination center where they were asked to
undergo various examinations, provide a blood sample, and
complete additional questionnaires. The response rates for
all the surveys exceeded 70%. The National Center for
Health Statistics Research Ethics Review Board granted
approval for the surveys, and participants were asked to sign
an informed consent form.
Predicted 10-year risk for CHD (angina pectoris,
myocardial infarction, coronary insufﬁciency, and CHD
death) and CVD (coronary death, myocardial infarction,
coronary insufﬁciency, angina, ischemic stroke, hemorrhagic
Table 1
Sociodemographic
National Health an
Number
Age, yrs*
Men, %y
White, %y
High school education or more, %yz
Systolic blood pressure, mm Hg*
Diastolic blood pressure, mm Hg*
Blood pressure treatment, %y
Total cholesterol, mg/dl*
HDLC, mg/dl*
Diabetes mellitus, %y
Current smoker, %y
CHD 10-yr risk, %*
Total
30–39 yrs
40–49 yrs
50–59 yrs
60–74 yrs
Men
Women
CVD 10-yr risk, %*
Total
30–39 yrs
40–49 yrs
50–59 yrs
60–74 yrs
Men
Women
*Mean (SE). yPercentage (SE). zSample siz
CHD ¼ coronary heart disease; CVD ¼ ca
Abbreviations
and Acronyms
CHD = coronary heart
disease
CVD = cardiovascular
disease
DBP = diastolic blood
pressure
HDLC = high-density
lipoprotein cholesterol
SBP = systolic blood
pressure
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2250stroke, transient ischemic attack,
intermittent claudication, and
heart failure) was determined from
risk algorithms derived from Fra-
mingham Heart Study data (5,6).
These algorithms include age,
concentrations of total cholester-
ol and high-density lipoprotein
cholesterol (HDLC), blood pres-
sure, treatment for hypertension,
smoking status, and diabetes mel-
litus. Treatment for hypertension
was based on self-reported cur-rent use of antihypertensive medication. Diabetes was
deﬁned as self-reported use of oral hypoglycemic medi-
cations or insulin or fasting plasma glucose 126 mg/dl.
The analyses were limited to fasting participants ages
30 to 74 years who attended the morning examination
and had a complete set of data. Participants who reported
having CVD (congestive heart failure, coronary heart
disease, angina pectoris, myocardial infarction, and
stroke) and pregnant women were excluded. Tests for
linear trend were conducted with orthogonal linear
contrasts. The SUDAAN statistical software packageVariables, Risk Factors, and Projected 10
d Nutrition Examination Survey
1999–2000 2001–2002 2003–2
1,140 1,272 1,10
46.9 (0.6) 47.4 (0.4) 47.4 (
48.7 (1.4) 48.9 (1.0) 48.3 (
71.3 (3.1) 75.5 (2.9) 75.6 (
76.5 (1.3) 84.1 (1.1) 83.8 (
122.1 (0.8) 122.3 (0.6) 121.5 (
74.1 (0.5) 74.5 (0.5) 72.8 (
15.7 (1.7) 17.4 (1.4) 18.7 (
208.0 (2.0) 207.0 (2.3) 204.3 (
50.3 (0.9) 51.8 (0.5) 54.4 (
7.3 (0.9) 9.2 (1.1) 8.3 (
22.7 (2.3) 25.0 (1.4) 25.5 (
7.2 (0.3) 7.3 (0.2) 6.7 (
2.8 (0.2) 2.8 (0.2) 2.3 (
5.5 (0.4) 5.9 (0.3) 5.5 (
10.4 (0.7) 9.5 (0.4) 9.1 (
14.5 (0.4) 14.8 (0.6) 13.2 (
9.5 (0.4) 9.8 (0.4) 9.1 (
5.0 (0.3) 4.8 (0.2) 4.5 (
9.2 (0.4) 9.4 (0.3) 8.8 (
2.9 (0.2) 2.9 (0.1) 2.5 (
6.3 (0.5) 7.0 (0.4) 6.4 (
12.6 (0.8) 11.9 (0.6) 11.8 (
21.4 (0.6) 22.1 (1.0) 19.8 (
11.8 (0.7) 12.4 (0.6) 11.9 (
6.6 (0.3) 6.6 (0.2) 5.9 (
e was 7,743 for education.
rdiovascular disease; HDLC ¼ high-density lipoprotein choles(RTI International, Durham, North Carolina) was used
to analyze the data to account for the complex sampling
design of the surveys. Sampling weights were used in the
analyses.
Results
The analyses included 7,751 participants. Sociodemographic
characteristics are show in Table 1. Mean levels of systolic
blood pressure (SBP) and diastolic blood pressure (DBP),
mean concentrations of total cholesterol, and the percentage
of current smokers decreased during the study period,
whereas mean concentrations of HDLC and the prevalence
of diabetes increased (Table 1).
Compared to the 7,751 participants included in the
analysis, relative differences in means and percentages of
demographic variables and risk factors for the 6 consecutive
2-year cycles combined among participants age 30 to 74
years who did not attend the morning examination were
2.3% or less except for diabetes (6.6% higher), current use of
antihypertensive medications (6.1% lower), and current
smoking (4.5% higher). However, the 95% conﬁdence
intervals for the estimates overlapped to some degree except
for SBP, DBP, and HDLC, which were all slightly worse-Year Risk for CHD and CVD Among Adults Age 30 to 74 Years,
004 2005–2006 2007–2008 2009–2010 p Linear Trend
3 1,122 1,476 1,638
0.5) 48.1 (0.7) 48.5 (0.6) 49.2 (0.4) 0.001
1.0) 46.9 (1.4) 47.5 (1.8) 47.9 (1.2) 0.476
3.8) 72.1 (2.7) 71.2 (3.5) 69.3 (3.3) 0.348
1.8) 85.2 (1.8) 82.3 (1.3) 83.1 (1.3) 0.005
0.7) 121.2 (0.7) 119.5 (0.7) 118.8 (0.5) <0.001
0.5) 70.8 (0.5) 71.7 (0.4) 70.2 (0.7) <0.001
1.5) 19.3 (1.4) 23.5 (1.2) 22.8 (1.9) <0.001
1.9) 204.2 (1.9) 200.7 (1.9) 202.0 (1.6) 0.003
0.8) 56.0 (0.3) 54.0 (0.6) 54.6 (0.6) <0.001
1.0) 8.1 (1.1) 8.7 (0.5) 11.6 (1.0) 0.013
2.3) 24.4 (2.3) 21.1 (1.9) 17.1 (1.2) 0.009
0.2) 6.3 (0.3) 6.3 (0.3) 6.5 (0.2) 0.005
0.2) 2.3 (0.1) 2.3 (0.2) 2.5 (0.1) 0.064
0.2) 5.2 (0.3) 4.4 (0.2) 4.8 (0.2) <0.001
0.6) 8.2 (0.4) 8.9 (0.4) 8.1 (0.4) 0.002
0.7) 11.9 (0.5) 11.2 (0.3) 11.6 (0.5) <0.001
0.5) 8.4 (0.3) 8.7 (0.4) 8.6 (0.3) 0.006
0.2) 4.5 (0.3) 4.1 (0.2) 4.7 (0.2) 0.039
0.3) 8.6 (0.4) 8.7 (0.5) 8.7 (0.2) 0.152
0.1) 2.6 (0.1) 2.6 (0.1) 2.7 (0.1) 0.138
0.3) 6.4 (0.4) 5.6 (0.3) 5.7 (0.2) 0.014
0.9) 10.3 (0.6) 11.6 (0.5) 10.2 (0.4) 0.007
1.0) 19.4 (0.9) 17.7 (0.8) 18.0 (0.7) <0.001
0.7) 11.2 (0.5) 12.0 (0.6) 11.5 (0.4) 0.480
0.3) 6.3 (0.6) 5.6 (0.3) 6.2 (0.2) 0.048
terol.
JACC Vol. 61, No. 22, 2013 Ford
June 4, 2013:2249–52 Trends in 10-Year Risk of CHD and CVD
2251among participants who did not attend the morning
examination.
The mean predicted 10-year risk for CHD decreased
signiﬁcantly from 7.2% during 1999 to 2000 to 6.5% during
2009 to 2010 (Table 1). However, the mean risk for CVD
showed no signiﬁcant improvement. When stratiﬁed by age,
the mean risk for CHD and CVD decreased signiﬁcantly in
the 3 oldest age groups. Mean risk for CHD decreased
signiﬁcantly among men and women, and mean risk for
CVD decreased signiﬁcantly among women. Mean risk for
CHD decreased signiﬁcantly among whites and decreasedFigure 1 Projected 10-Year Risk for CHD
Mean (95% conﬁdence interval) projected 10-year risk for (A) coronary heart disease (CH
ethnicity and survey period, National Health and Nutrition Examination Survey. Mean predi
predicted risk for CHD and cardiovascular disease among African-American adults increanonsigniﬁcantly among Mexican Americans. Mean risk for
CHD and CVD increased nonsigniﬁcantly among African
Americans (Fig. 1).
Discussion
The current analysis shows that predicted 10-year risk for
CHD but not CVD improved modestly and signiﬁcantly
during the 10-year time period. The declining predicted risk
for CHD in the presence of large increases in obesity and
diabetes in the United States may be attributed in largeD) and (B) cardiovascular disease for 7,751 adults age 30 to 74 years, by race or
cted 10-year risk for CHD among white adults decreased signiﬁcantly, whereas mean
sed nonsigniﬁcantly.
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2252measure to improvements in the prevalence of smoking,
mean levels of SBP and DBP, and mean concentrations of
total cholesterol and HDLC. In the absence of increasing
prevalence of diabetes, predicted risk would have declined at
a stronger pace.
The lack of signiﬁcant improvements in mean SBP and
concentrations of total cholesterol coupled to strong
increases in prevalent diabetes among African Americans
largely account for the racial differences (data not shown).
Among whites, signiﬁcant and larger improvements were
noted for mean levels of SBP and DBP as well as mean
concentrations of total cholesterol and HDLC. The change
in diabetes from 6.4% to 10.3% among whites (p for linear
trend ¼ 0.115) proved less than the change from 7.9% to
14.1% among African Americans (p for linear trend ¼
0.008).
Changing the course of predicted risk for CHD and
CVD among African-American adults will require both
population and clinical approaches. Because blood pressure,
lipids, and diabetes have powerful behavioral underpinnings,
effective and efﬁcient population-based approaches in
promoting heart-healthy diets and physical activity among
African Americans are fundamental to achieving desirable
change (7). The National Prevention Strategy emphasizes
the need for eliminating health disparities and contains
a series of recommendations aimed at improving diets and
physical activity levels (8). Complementary to population-
based approaches is the need for clinical approaches in
managing hypertension, dyslipidemias, and diabetes to
eliminate health disparities in the treatment for abnormal
levels of risk factors (9,10). Assuring access to quality
medical care and availability of affordable medications will
help in improving control of abnormal risk factor levels.
The different impressions conveyed by the trajectories for
predicted 10-year risk of CHD and CVD may seem
counterintuitive given that both risk algorithms use a similar
set of risk factors to calculate risk. The risk algorithm for
CHD uses both SBP and DBP but not treatment for
hypertension, whereas the risk algorithm for CVD uses only
SBP but does make an allowance for treatment of elevated
blood pressure. Also, the manner in which the variables are
speciﬁed in the risk algorithms differs. Moreover, angina
pectoris, myocardial infarction, coronary insufﬁciency, and
CHD death represented the endpoints used to develop the
risk equation for CHD, whereas the aforementioned
endpoints as well as ischemic stroke, hemorrhagic stroke,
transient ischemic attack, intermittent claudication, and
heart failure represented the endpoints used to develop the
risk equation for CVD. An examination of the risk functions
for congestive heart failure and stroke derived from Fra-
mingham Heart Study data shows different sets of predictors
for the risk functions. For example, the risk function for
predicting congestive heart failure does not include lipids or
smoking status, and the risk function for predicting stroke
does not include lipids (11). Furthermore, there are differ-
ences in the strength of the relationships between the variousrisk factors employed by the risk equations and the speciﬁc
endpoints that comprise CVD. Thus, the risk factors that
were part of the risk equations for CHD and CVD may be
more speciﬁc to CHD than to CVD. These differences may
have accounted in whole or in part for the different trajec-
tories in predicted risk.
Conclusions
Since 1999 to 2000, predicted 10-year risk for CHD has
declined signiﬁcantly but modestly. In contrast, the small
decline in predicted 10-year risk for CVD was not statisti-
cally signiﬁcant. The trend in predicted 10-year risk for
CHD is consistent with regional U.S. reports about
declining incident CHD and suggests that a future decline
in the incidence of CHD is possible. Nevertheless, the
modest size of the improvements in predicted risk cautions
that future gains in cardiovascular health cannot be auto-
matically assumed and indicates that much work in
advancing cardiovascular health in the United States looms
ahead.
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